Drugs / AGN-231868
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04030962 | Mar 2020 → Mar 2022 | dry eye syndrome | AbbVie | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGN-231868 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04030962 ↗ |
| Route | Topical | “Ophthalmic solution administered as a topical eye drop” NCT04030962 ↗ |